--- title: Why Your Path to Sustainability Should Start With ESG description: ESG is reshaping the pharmaceutical industry, discover how new regulations are driving transparency, compliance, and sustainable growth. image: https://blog.pqegroup.com/hubfs/Path%20to%20Sustainability%20ESG_Blog-2.webp --- [![Logo PQE Group - azzurro - 2024](https://blog.pqegroup.com/hs-fs/hubfs/Logo%20PQE%20Group%20-%20azzurro%20-%202024.png?width=2000&height=721&name=Logo%20PQE%20Group%20-%20azzurro%20-%202024.png "Logo PQE Group - azzurro - 2024")](https://www2.pqegroup.com) - [Home](https://www2.pqegroup.com/) - [Industry](https://www2.pqegroup.com/industry/) - [Pharma & API](https://www2.pqegroup.com/pharma-api/) - [Medical Device](https://www2.pqegroup.com/medical-device/) - [Biotech](https://www2.pqegroup.com/biotech/) - [Startup](https://www2.pqegroup.com/startup/) - [Veterinary](https://www2.pqegroup.com/veterinary/) - [Services](https://www2.pqegroup.com/services/) - [Data Integrity](https://www2.pqegroup.com/data-integrity/) - [Digital Governance](https://www2.pqegroup.com/digital-governance/) - [Engineering](https://www2.pqegroup.com/engineering/) - [Commissioning, Qualification and Validation (CQV)](https://www2.pqegroup.com/commissioning-qualification-validation/) - [Quality Compliance](https://www2.pqegroup.com/quality-compliance/) - [Laboratory Excellence](https://www2.pqegroup.com/laboratory-excellence/) - [Regulatory Affairs](https://www2.pqegroup.com/regulatory-affairs/) - [Audits](https://www2.pqegroup.com/audits/) - [Training](https://www2.pqegroup.com/training/) - [Clinical Research](https://www2.pqegroup.com/clinical-research-services/) - [Pharmacovigilance](https://www2.pqegroup.com/pharmacovigilance/) - About - [About Us](https://www2.pqegroup.com/about/) - [ESG](https://www2.pqegroup.com/about/csr/) - [Women in STEM](https://www2.pqegroup.com/about/women-in-stem/) - Resources - [News & Press](https://www2.pqegroup.com/news/) - [Webinars](https://www2.pqegroup.com/webinars/) - [Blog](https://blog.pqegroup.com/) - [Careers](https://www2.pqegroup.com/careers/) - [Contact Us](https://www2.pqegroup.com/contact-us/) ![](https://blog.pqegroup.com/hubfs/blank-user.png) Federico Angeloro ESG Manager @PQE Group # **Why Your Path to Sustainability Should Start With ESG** [GxP Compliance](https://blog.pqegroup.com/tag/gxp-compliance) Sustainability has become one of the most important business priorities for pharmaceutical companies seeking to meet regulatory requirements and environmental goals. Although the pharmaceutical industry is not usually associated with pollution and waste, there is no denying the environmental and operational footprint created by its complex global supply chains. As stakeholders, communities, and investors raise their expectations for transparency and accountability, organizations are under more pressure than ever to demonstrate their commitment to sustainable and responsible business practices. For companies that want to gain stakeholder trust and build a long-term strategy around sustainability, ESG (Environmental, Social, and Governance) is no longer just a “nice-to-have”; it is now a strategic asset. ## **What Does ESG Mean In The Pharmaceutical Industry ?** In 2026, having sustainability initiatives in place is no longer enough for pharmaceutical businesses to claim they are sustainable. To demonstrate how effective these initiatives are, companies are now required to measure and report their impact in a transparent and clear manner. Organizations that approach ESG as a strategic framework to assess the social, environmental, and governance impact of their pharmaceutical operations, rather than treating it as a simple checkbox or a tool to greenwash their image, are attracting more investment, top-tier talent, and strengthening their reputation compared with their competitors.   ## **ESG Reporting Regulations In Life Sciences ** Many EU companies and companies with offices in the EU are required to disclose information regarding the impact of their operations on ESG, a move that transforms sustainability reporting from voluntary to mandatory for certain businesses. Pharmaceutical companies with a presence in Europe, when disclosing their sustainability performance, must adhere to specific Sustainability Reporting Standards and report on key topics such as carbon emissions, pollution and waste, labor practices, anti-corruption policies, and human rights in supply chains, among others.     ## **Impact Of Regulatory Changes On Compliance In Life Sciences   ** The shift from voluntary to mandatory ESG reporting is already affecting how pharmaceutical businesses, and life sciences organizations more broadly, operate and interact with the environment and the communities in which they work. As companies that invest immense resources in improving people’s lives, it is only right that these efforts do not come at a cost to the environment or local communities. Regulatory requirements bring a range of benefits to both stakeholders and businesses, chief among them transparency and industry-wide consistency. By making sustainability a measurable metric that can be analyzed quantitatively, they enable stakeholders to evaluate a company from both a financial and sustainability perspective and make informed decisions. Moreover, we have to take into account that many parallel industries such as consulting are not required to by law to comply with these regulatory requirements, however they are expected to meet these obligatory requirements by their large clients.     ## **Current Challenges****In****ESG Reporting Regulations**   The pharmaceutical industry is complex and highly regulated, and when the many stakeholders and suppliers that make up its intricate supply chains are considered, it becomes clear that implementing effective ESG reporting regulations is a significant challenge, though not an impossible one. To provide an accurate picture of their sustainability performance, pharmaceutical companies must collect both internal and external data, including third-party supplier data from across the entire supply chain, and ensure that this information is processed and reported in line with the regulatory requirements. Another major challenge pharmaceutical companies face is determining what constitutes a material sustainability issue for the business and how it should be measured.   ## **The Way Forward ** Regardless of the challenges currently faced by pharmaceutical companies in ESG reporting, it does not change the fact that these businesses consume immense resources and impact local communities through their operations. For the industry to continue saving and improving lives in a sustainable manner, there must be a greater emphasis on ESG across the entire value chain, from the way resources are sourced to how they are utilized and disposed of, as well as how businesses engage with their employees and society. Pharmaceutical companies must seek sustainable ways to expand access to medicines and address current industry challenges while ensuring that innovation and financial gains do not come at the expense of environmental protection, ethical governance, or social responsibility.   ![Path to Sustainability ESG_Blog](https://blog.pqegroup.com/hs-fs/hubfs/Path%20to%20Sustainability%20ESG_Blog.webp?width=2000&name=Path%20to%20Sustainability%20ESG_Blog.webp) ## Want to know more? Our consultants can support you to achieve the full compliance of your products. Visit our **[Quality Compliance](https://www2.pqegroup.com/quality-compliance/)** dedicated page or get in touch with us to learn how PQE Group can help your business. [Contact us](https://www2.pqegroup.com/contact-us/) #### More on this topic [GxP Compliance ![The FDA Guide to AI in Drug Development](https://blog.pqegroup.com/hubfs/FDA%20guidance%20on%20AI_Blog.webp)](https://blog.pqegroup.com/gxp-compliance/the-fda-guide-to-ai-in-drug-development) 30 Jun 2026 ## [The FDA Guide to AI in Drug Development Read more about how the FDA is redefining AI in drug development from regulatory guidance to compliance expectations.](https://blog.pqegroup.com/gxp-compliance/the-fda-guide-to-ai-in-drug-development) [GxP Compliance ![CSA Validation Strategies in SAP S/4HANA®](https://blog.pqegroup.com/hubfs/CSA%20SAP%204%20HANA_Blog-2.webp)](https://blog.pqegroup.com/gxp-compliance/csa-validation-strategies-in-sap-s/4hana) 27 May 2026 ## [CSA Validation Strategies in SAP S/4HANA® Discover CSA in SAP S/4HANA validation and its digital approach focused on risk and efficiency.](https://blog.pqegroup.com/gxp-compliance/csa-validation-strategies-in-sap-s/4hana) [GxP Compliance ![From QSIT to CP 7382.850: FDA Inspection FAQs](https://blog.pqegroup.com/hubfs/FDA%20Inspection%20FAQs_Site%20Banner.jpg)](https://blog.pqegroup.com/gxp-compliance/from-qsit-to-cp-7382.850-fda-inspection-faq) 25 May 2026 ## [From QSIT to CP 7382.850: FDA Inspection FAQs Understand FDA QSIT inspection changes and CP 7382.850. Explore key FAQs on audits, checklists, sampling, and risk‑based inspection expectations.](https://blog.pqegroup.com/gxp-compliance/from-qsit-to-cp-7382.850-fda-inspection-faq) ![new PQE logo white tagline](https://blog.pqegroup.com/hubfs/new%20PQE%20logo%20white%20tagline.png) ISO 9001 Certified compliance services provider since 1998.   ![Logo ISO 9001](https://blog.pqegroup.com/hs-fs/hubfs/Logo%20ISO%209001.png?width=125&name=Logo%20ISO%209001.png)   - Discover PQE - [Work with PQE](https://www2.pqegroup.com/careers/) - [Locations](https://www2.pqegroup.com/contact-us/#locations) - [About](https://www2.pqegroup.com/about/) - [Blog](https://blog.pqegroup.com/) - Useful Links - [Privacy Notice](https://www2.pqegroup.com/privacy-notice/) - [Cookie Policy](https://www2.pqegroup.com/cookie-policy/) - [Model of Organization](https://www2.pqegroup.com/model-of-organization/) - [Ethical Code](https://www2.pqegroup.com/ethical-code/) English CHANGE LANGUAGE Copyright **2024** | Proudly powered by **PQE Group Creative Team** [LinkedIn](https://www.linkedin.com/company/pqe-group) [![twitter](https://blog.pqegroup.com/hubfs/twitter-w.png) Twitter](https://twitter.com/PQEGroup) [Facebook](https://www.facebook.com/PQEGroup/) [Instagram](https://www.instagram.com/lifeatpqe) [YouTube](https://www.youtube.com/c/PQEGroup) [Xing](https://www.xing.com/pages/pqegroup)